Initial trials demonstrate that Retatrutide – a dual stimulator of GLP-1 and glucose-dependent insulinotropic polypeptide receptors – offers a significant breakthrough in weight reduction programs . Beyond existing treatments , Retatrutide shows to influence food intake and metabolic expenditure